<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)
INCYTE PHARMACEUTICALS, INC.
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE
(Title of Class of Securities)
45337C 10 2
---------------------------------------------
(CUSIP Number)
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities
of that section of the Act but shall be subject to all other provisions of the
Act.
Page 1 of 13 Pages
<PAGE>
CUSIP No. 45337C 10 2 13G Page 2 of 13 Pages
- --------------------------------------------------------------------------------
1. Names of Reporting Persons Jeffrey J. Collinson
S.S. or I.R.S. Identification
Nos. of Above Persons ###-##-####
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization U.S. Citizen
- --------------------------------------------------------------------------------
5. Sole Voting Power 6,005
Number of -----------------------------------------------------
Shares
Beneficially 6. Shared Voting Power 418,892
Owned by -----------------------------------------------------
Each
Reporting 7. Sole Dispositive Power 6,005
Person -----------------------------------------------------
With
8. Shared Dispositive Power 418,892
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned
by Each Reporting Person 424,897
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount
in Row 9 Excludes Certain Shares [ ]
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 4.1%
- --------------------------------------------------------------------------------
12. Type of Reporting Person IN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 45337C 10 2 13G Page 3 of 13 Pages
- --------------------------------------------------------------------------------
1. Names of Reporting Persons Timothy F. Howe
S.S. or I.R.S. Identification
Nos. of Above Persons
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization U.S. Citizen
- --------------------------------------------------------------------------------
5. Sole Voting Power 0
Number of -----------------------------------------------------
Shares
Beneficially 6. Shared Voting Power 410,000
Owned by -----------------------------------------------------
Each
Reporting 7. Sole Dispositive Power 0
Person -----------------------------------------------------
With
8. Shared Dispositive Power 410,000
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned
by Each Reporting Person 410,000
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount
in Row 9 Excludes Certain Shares [ ]
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 4.0%
- --------------------------------------------------------------------------------
12. Type of Reporting Person IN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 45337C 10 2 13G Page 4 of 13 Pages
- --------------------------------------------------------------------------------
1. Names of Reporting Persons Schroder Ventures
Limited Partnership
S.S. or I.R.S. Identification
Nos. of Above Persons
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
- --------------------------------------------------------------------------------
5. Sole Voting Power 247,123
Number of -----------------------------------------------------
Shares
Beneficially 6. Shared Voting Power -0-
Owned by -----------------------------------------------------
Each
Reporting 7. Sole Dispositive Power 247,123
Person -----------------------------------------------------
With
8. Shared Dispositive Power -0-
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned
by Each Reporting Person 247,123
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount
in Row 9 Excludes Certain Shares [ ]
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 2.4%
- --------------------------------------------------------------------------------
12. Type of Reporting Person PN
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 45337C 10 2 13G Page 5 of 13 Pages
- --------------------------------------------------------------------------------
1. Names of Reporting Persons Schroders Incorporated
S.S. or I.R.S. Identification
Nos. of Above Persons
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
- --------------------------------------------------------------------------------
5. Sole Voting Power 100,000
Number of -----------------------------------------------------
Shares
Beneficially 6. Shared Voting Power -0-
Owned by -----------------------------------------------------
Each
Reporting 7. Sole Dispositive Power 100,000
Person -----------------------------------------------------
With
8. Shared Dispositive Power -0-
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned
by Each Reporting Person 100,000
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount
in Row 9 Excludes Certain Shares [ ]
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 1.0%
- --------------------------------------------------------------------------------
12. Type of Reporting Person CO
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 45337C 10 2 13G Page 6 of 13 Pages
- --------------------------------------------------------------------------------
1. Names of Reporting Persons Schroder Ventures
U.S. Trust
S.S. or I.R.S. Identification
Nos. of Above Persons
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization Bermuda
- --------------------------------------------------------------------------------
5. Sole Voting Power 62,877
Number of -----------------------------------------------------
Shares
Beneficially 6. Shared Voting Power -0-
Owned by -----------------------------------------------------
Each
Reporting 7. Sole Dispositive Power 62,877
Person -----------------------------------------------------
With
8. Shared Dispositive Power -0-
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned
by Each Reporting Person 62,877
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount
in Row 9 Excludes Certain Shares [ ]
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 0.6%
- --------------------------------------------------------------------------------
12. Type of Reporting Person OO
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 45337C 10 2 13G Page 7 of 13 Pages
- --------------------------------------------------------------------------------
1. Names of Reporting Persons Collinson Howe Venture
Partners, Inc. (formerly
known as Schroder
Ventures Advisers,
Incorporated)
S.S. or I.R.S. Identification
Nos. of Above Persons
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
- --------------------------------------------------------------------------------
5. Sole Voting Power 100
Number of -----------------------------------------------------
Shares
Beneficially 6. Shared Voting Power -0-
Owned by -----------------------------------------------------
Each
Reporting 7. Sole Dispositive Power 100
Person -----------------------------------------------------
With
8. Shared Dispositive Power -0-
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned
by Each Reporting Person 100
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount
in Row 9 Excludes Certain Shares [ ]
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 0%
- --------------------------------------------------------------------------------
12. Type of Reporting Person CO
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 45337C 10 2 13G Page 8 of 13 Pages
Item 1(a) Name of Issuer: Incyte Pharmaceuticals, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
3330 Hillview Avenue, Palo Alto, CA 94304
Item 2(a) Name of Person Filing: Jeffrey J. Collinson,
Timothy F. Howe, Schroder Ventures Limited
Partnership, Schroders Incorporated, Schroder
Ventures U.S. Trust, and Collinson Howe Venture
Partners, Inc.
Item 2(b) Address of Principal Business Office or, if None,
-------------------------------------------------
Residence: The address of the principal business
---------
office of each of the filing entities and
Mr. Collinson and Mr. Howe is Collinson Howe
Venture Partners, Inc., 1055 Washington
Boulevard, Stamford, CT 06901.
Item 2(c) Citizenship: Schroder Ventures Limited
-----------
Partnership is a limited partnership organized
under the laws of the State of Delaware.
Mr. Collinson and Mr. Howe are United States
citizens. Schroder Ventures U.S. Trust is a
Bermuda trust. Schroders Incorporated and
Collinson Howe Venture Partners, Inc. are
Delaware corporations.
Item 2(d) Title of Class of Securities Common Stock,
----------------------------
$.001 par value ("Common Stock")
Item 2(e) CUSIP Number: 45337C 10 2
------------
Item 3. If this statement is filed pursuant to Rule 13d-1(b) or
-------------------------------------------------------
13d-2(b), check whether the person filing is a:
----------------------------------------------
(a) [ ] Broker or Dealer registered under
section 15 of the Act
(b) [ ] Bank as defined in section 3(a)(6) of the
Act
(c) [ ] Insurance Company as defined in section
3(a)(19) of the Act
(d) [ ] Investment Company registered under
section 8 of the Investment Company Act
(e) [ ] Investment Adviser registered under
section 203 of the Investment Advisers Act
of 1940
<PAGE>
CUSIP No. 45337C 10 2 13G Page 9 of 13 Pages
(f) [ ] Employee Benefit Plan, Pension Fund which
is subject to the provisions of the
Employee Retirement Income Security Act of
1974 or Endowment Fund
(g) [ ] Parent Holding Company, in accordance with
section 240.13d-1(b)(ii)(G)
(h) [ ] Group, in accordance with section
240.13d-1(b)(1)(ii)(H)
Not Applicable.
Item 4. Ownership.
---------
Not Applicable.
Item 5. Ownership of Five Percent or Less of a Class.
--------------------------------------------
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following: [X]
Item 6. Ownership of More than Five Percent on Behalf of
------------------------------------------------
Another Person.
--------------
Not Applicable.
Item 7. Identification and Classification of the
----------------------------------------
Subsidiary Which Acquired the Security Being
--------------------------------------------
Reported on by the Parent Holding Company.
-----------------------------------------
Not Applicable.
Item 8. Identification and Classification of Members of
-----------------------------------------------
the Group.
---------
Group is filing pursuant to 13d-1(c). An exhibit containing
the identities of each member of the group is attached hereto as Exhibit I.
Item 9. Notice of Dissolution of Group.
------------------------------
Not Applicable.
<PAGE>
CUSIP No. 45337C 10 2 13G Page 10 of 13 Pages
Item 10. Certification.
-------------
Not Applicable. This statement on Schedule 13G is not being filed
pursuant to Rule 13d-1(b).
<PAGE>
CUSIP No. 45337C 10 2 13G Page 11 of 13 Pages
Exhibit Index
Exhibit Number Page Number
I 13
<PAGE>
CUSIP No. 45337C 10 2 13G Page 12 of 13 Pages
Signature
---------
After reasonable inquiry and to the best of my knowledge and belief,
each of the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Dated: February 10, 1997.
SCHRODER VENTURES LIMITED
PARTNERSHIP
By /s/ JEFFREY J. COLLINSON
-------------------------------------
Jeffrey J. Collinson
Attorney-in-Fact
SCHRODER VENTURES U.S. TRUST
By /s/ JEFFREY J. COLLINSON
-------------------------------------
Jeffrey J. Collinson
Attorney-in-Fact
SCHRODERS, INCORPORATED
By /s/ JEFFREY J. COLLINSON
-------------------------------------
Jeffrey J. Collinson
Attorney-in-Fact
COLLINSON HOWE VENTURE
PARTNERS, INC.
By /s/ JEFFREY J. COLLINSON
-------------------------------------
Jeffrey J. Collinson
President and Sole Shareholder
JEFFREY J. COLLINSON
By /s/ JEFFREY J. COLLINSON
-------------------------------------
TIMOTHY F. HOWE
By /s/ TIMOTHY F. HOWE
-------------------------------------
<PAGE>
CUSIP No. 45337C 10 2 13G Page 13 of 13 Pages
EXHIBIT I
---------
AGREEMENT
---------
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934,
the undersigned hereby agree that only one statement containing the information
required on Schedule 13G need be filed with respect to ownership by each of the
undersigned of shares of Common Stock of Incyte Pharmaceuticals, Inc.
This Agreement may be executed in any number of counterparts, each of
which shall be deemed an original.
Dated: February 10, 1997.
SCHRODER VENTURES LIMITED
PARTNERSHIP
By /s/ JEFFREY J. COLLINSON
-------------------------------------
Jeffrey J. Collinson
Attorney-in-Fact
SCHRODER VENTURES U.S. TRUST
By /s/ JEFFREY J. COLLINSON
-------------------------------------
Jeffrey J. Collinson
Attorney-in-Fact
SCHRODERS, INCORPORATED
By /s/ JEFFREY J. COLLINSON
-------------------------------------
Jeffrey J. Collinson
Attorney-in-Fact
COLLINSON HOWE VENTURE
PARTNERS, INC.
By /s/ JEFFREY J. COLLINSON
-------------------------------------
Jeffrey J. Collinson
President and Sole Shareholder
JEFFREY J. COLLINSON
By /s/ JEFFREY J. COLLINSON
-------------------------------------
TIMOTHY F. HOWE
By /s/ TIMOTHY F. HOWE
-------------------------------------
